255 related articles for article (PubMed ID: 17552043)
1. Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy?
Castellino G; Govoni M; Prandini N; Limpido G; Bernardi S; Campione D; Lanza F; Trotta F
J Rheumatol; 2007 Jul; 34(7):1497-501. PubMed ID: 17552043
[TBL] [Abstract][Full Text] [Related]
2. Is thrombocytosis always an indicator of autosplenectomy in patients with systemic lupus erythematosus?
Üsküdar Cansu D; Üsküdar Teke H; Musmul A; Korkmaz C
Rheumatol Int; 2018 Feb; 38(2):239-247. PubMed ID: 29119304
[TBL] [Abstract][Full Text] [Related]
3. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
4. Autosplenectomy and antiphospholipid antibodies in systemic lupus erythematosus: A pathogenetic relationship?
Santilli D; Govoni M; Prandini N; Rizzo N; Trotta F
Semin Arthritis Rheum; 2003 Oct; 33(2):125-33. PubMed ID: 14625820
[TBL] [Abstract][Full Text] [Related]
5. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
6. Splenic hypofunction in systemic lupus erythematosus.
Childs JC; Adelizzi RA; Dabrow MB; Freed N
J Am Osteopath Assoc; 1994 May; 94(5):414-5. PubMed ID: 8056631
[TBL] [Abstract][Full Text] [Related]
7. Diffuse calcifications of the spleen: a novel association with systemic lupus erythematosus.
Tieng AT; Sadow CA; Hochsztein JG; Putterman C
Semin Arthritis Rheum; 2011 Oct; 41(2):187-93. PubMed ID: 21185064
[TBL] [Abstract][Full Text] [Related]
8. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
9. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
Chen JL; Huang XM; Zeng XJ; Wang Y; Zhou MX; Ma YH; Li RS; Shen T
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1330-3. PubMed ID: 17727778
[TBL] [Abstract][Full Text] [Related]
10. Autosplenectomy in systemic lupus erythematosus.
Uthman I; Soucy JP; Nicolet V; Senécal JL
J Rheumatol; 1996 Oct; 23(10):1806-10. PubMed ID: 8895164
[TBL] [Abstract][Full Text] [Related]
11. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients.
McMahon MA; Keogan M; O'Connell P; Kearns G
Ir Med J; 2006; 99(10):296-8. PubMed ID: 17274170
[TBL] [Abstract][Full Text] [Related]
13. Splenectomy in systemic lupus erythematosis.
Gruenberg JC; VanSlyck EJ; Abraham JP
Am Surg; 1986 Jul; 52(7):366-70. PubMed ID: 3729170
[TBL] [Abstract][Full Text] [Related]
14. Persistent thrombocytosis in systemic lupus erythematosus. Activity, reactivity, or what?
Sánchez-Guerrero SA; Sánchez-Guerrero J
J Rheumatol; 2007 Jul; 34(7):1441-2. PubMed ID: 17611959
[No Abstract] [Full Text] [Related]
15. Suspects in the tale of lupus-associated thrombocytopenia.
Ziakas PD; Routsias JG; Giannouli S; Tasidou A; Tzioufas AG; Voulgarelis M
Clin Exp Immunol; 2006 Jul; 145(1):71-80. PubMed ID: 16792676
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
18. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
19. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
